Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-20

FDA Approved: ETYQA — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for ETYQA (estradiol and norethindrone acetate) from Aurobindo Pharma Limited. This action pertains to a supplementa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ETYQA (ESTRADIOL AND NORETHINDRONE ACETATE)

Snippet

SUPPL AP for ETYQA (ESTRADIOL AND NORETHINDRONE ACETATE)